Personalized medicine arrives for patients with colorectal cancer: Deal with it

American Journal of Hematology/ Oncology

Volumn 8, Issue 4, 2009, Pages

  Saltz, Leonard B ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; PANITUMUMAB;

CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DRUG INDICATION; GENE MUTATION; HUMAN; METASTASIS; NOTE; ONCOGENE K RAS; PROGNOSIS;

EID: 69949178715     PISSN: 15429520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (1)

1. Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359:1757-1765.